Patents by Inventor Zhenbin Qian

Zhenbin Qian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of SAA1B/B homozygote in the prognosis and diagnosis of liver cirrhosis
    Patent number: 9708663
    Abstract: Provided is uses of SAA1?/?(1.5/1.5) homozygote in prognosis and/diagnosis of liver cirrhosis, and in preparation of a reagent for liver cirrhosis prognosis and/or liver cirrhosis diagnosis. Recognition of liver cirrhosis susceptible populations can be achieved by detection of human SAA1?/? homozygote and non-SAA1?/? homozygote through real-time fluorescence quantitative allele specific PCR.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: July 18, 2017
    Assignee: DIASYS DIAGNOSTIC SYSTEMS (SHANGHAI) CO., LTD.
    Inventors: Rongfang Wang, Jun Wu, Yan Zhang, Zhenbin Qian
  • USE OF SAA1 beta/beta HOMOZYGOTE IN THE PROGNOSIS DIAGNOSIS AND DIAGNOSIS OF LIVER CIRRHOSIS
    Publication number: 20150031027
    Abstract: Provided is uses of SAA1?/?(1.5/1.5) homozygote in prognosis and/diagnosis of liver cirrhosis, and in preparation of a reagent for liver cirrhosis prognosis and/or liver cirrhosis diagnosis. Recognition of liver cirrhosis susceptible populations can be achieved by detection of human SAA1?/? homozygote and non-SAA1?/? homozygote through real-time fluorescence quantitative allele specific PCR.
    Type: Application
    Filed: March 19, 2012
    Publication date: January 29, 2015
    Inventors: Rongfang Wang, Jun Wu, Yan Zhang, Zhenbin Qian